<--- Back to Details
First PageDocument Content
Cancer / Health / Clinical medicine / RTT / Infectious causes of cancer / Microarrays / Ribbon symbolism / Bladder cancer / Gene expression profiling / Gene signature / Transitional cell carcinoma / Breast cancer
Date: 2012-03-26 09:26:11
Cancer
Health
Clinical medicine
RTT
Infectious causes of cancer
Microarrays
Ribbon symbolism
Bladder cancer
Gene expression profiling
Gene signature
Transitional cell carcinoma
Breast cancer

Published OnlineFirst January 6, 2012; DOI:.CCRCombination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer Markus R

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Download Document from Source Website

File Size: 746,69 KB

Share Document on Facebook

Similar Documents

Edorium J Disabil Rehabil 2015;1:9–11. www.edoriumjournals.com/ej/dr Letter to Editors	  Massoni et al. 

Edorium J Disabil Rehabil 2015;1:9–11. www.edoriumjournals.com/ej/dr Letter to Editors Massoni et al. 

DocID: 1ru4d - View Document

000  Kinect Based Method for the BCCT Quantitative 3D evaluationHélder P. Oliveira1

000 Kinect Based Method for the BCCT Quantitative 3D evaluationHélder P. Oliveira1

DocID: 1rovH - View Document

Compare your diagnosis with a million others. PenProfiler. Does your Mammography Information System offer the newest dimension in diagnosis?

Compare your diagnosis with a million others. PenProfiler. Does your Mammography Information System offer the newest dimension in diagnosis?

DocID: 1rnF0 - View Document

CAMPAIGN AT A GLANCE Breast Cancer Action takes on pinkwashers: corporations or organizations that peddle products linked to breast cancer while claiming to care about

CAMPAIGN AT A GLANCE Breast Cancer Action takes on pinkwashers: corporations or organizations that peddle products linked to breast cancer while claiming to care about

DocID: 1rnAP - View Document

· METASTATIC BREAST CANCER ·  Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD  Abstract

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document